Kapil Dhingra;Brian Higgins;Richard J. Lee;Kathryn Packman;Fei Su;Kenneth Kolinsky;Brian Lestini
发明人:
Kapil Dhingra,Brian Higgins,Kenneth Kolinsky,Richard J. Lee,Brian Lestini,Kathryn Packman,Fei Su
申请号：
US13206557
公开号：
US20120045434A1
申请日:
2011.08.10
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an EGFR inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer.
